Key result
Orlistat significantly improved the pulsatility index compared to placebo in healthy obese subjects (p < 0.002), indicating a favorable effect on peripheral arterial circulation.
Why the study?
Techniques for evaluating early functional arterial wall changes have limitations, prompting evaluation of the pulsatility index association with metabolic parameter changes under insulin resistance.
RCT (n=30)
double blind
randomized
May improve peripheral flow in obese patients; hypothesis-generating and requires larger trials before practice change.
Background/Aim. Prolonged hyperinsulinemia accelerates the process of endothelial dysfunction and arteriosclerotic changes affecting the development of cardiovascular and cerebrovascular diseases. There are various measuring techniques for the evaluation of early functional changes in the arterial wall such as: flow-mediated endothelium-dependent vasodilation, impulse wave analysis, intima-media thickness assessment, venous plethysmography and so on; however, each has certain limitations in results interpretation. The aim of this study was to indicate the association of the pulsatility index (PI) that shows peripheral arterial contractility, with the changes in metabolic parameters under insulin resistance conditions. Methods. The study included a total of 30 healthy obese subjects with the values of body mass index more than 30 kg/m2, randomized with double blind design into two groups: placebo and orlistat. The extent of insulin sensitivity was calculated on the basis of glycemia and insulinemia values using an appropriate formula. Results. The obtained results suggest a statistically significant improvement in the PI index in the orlistat group (p < 0.002), while there was no such improvement in the placebo group. Conclusion. The results obtained in this study indicate the improvement in insulin sensitivity within early arteriosclerosis is a significantly favorable effect of orlistat on peripheral arterial circulation additionally supported by the reduction in levels of lipid fractions, especially triglycerides. Early hemodynamic changes under conditions of the reduced insulin resistance are characterized by the increase in arterial wall contractility evaluated by the PI determination.
No takes yet. Share an insight, caveat, or question.
Hajdukovic et al. (2018) conducted an RCT in Obesity (n=30). Orlistat vs. Placebo was evaluated on Pulsatility index (PI) (p=<0.002). Orlistat significantly improved the pulsatility index compared to placebo in healthy obese subjects (p < 0.002), indicating a favorable effect on peripheral arterial circulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: